Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Needham Maintains Buy on LendingTree, Lowers Price Target to $62

Needham analyst Mayank Tandon maintains LendingTree (NASDAQ:TREE) with a Buy and lowers the price target from $105 to $62.

byBenzinga Newsdesk

June 24, 2022

1 minute read

Needham analyst Mayank Tandon maintains LendingTree (NASDAQ:TREE) with a Buy and lowers the price target from $105 to $62.

News

Why Acceleron Pharma Stock Is Trading Higher Today

By Tyree Gorges

Today, 12:44 PM

Acceleron Pharma (NASDAQ: XLRN) shares are trading higher after Bloomberg reported the company is in talks for a potential $11 billion buyout.

XLRN

Jack Dorsey Says This Was His ‘Biggest Failing’ At Twitter

By Shanthi Rexaline

Today, 12:44 PM

Twitter, Inc.'s (NASDAQ: TWTR) co-founder Jack Dorsey, who gave up his chief executive officer role at the social media platform late last year, shared his insights into what it would take to reinvigorate the platform.

TESLA

Benzinga’s Top Ratings Upgrades, Downgrades For October 14, 2021

By Benzinga Insights

Today, 12:44 PM

Upgrades

ABT

Justice Department Opposes Revealing Details Related To Trump Search Affidavit: Not In ‘Public Interest’

By Shivdeep Dhaliwal

Today, 12:44 PM

The U.S. Department of Justice (DoJ) is opposing the release of details contained in an affidavit that was used to argue that a probable cause existed for the search of Mar-a-Lago, the Palm Beach, Florida estate belonging to former President Donald Trump.

DWAC

Needham Maintains Buy on LendingTree, Lowers Price Target to $62

Related Posts

Why Acceleron Pharma Stock Is Trading Higher Today

Jack Dorsey Says This Was His ‘Biggest Failing’ At Twitter

Benzinga’s Top Ratings Upgrades, Downgrades For October 14, 2021

Justice Department Opposes Revealing Details Related To Trump Search Affidavit: Not In ‘Public Interest’